SPECT/CT-based dosimetry of salivary glands and iodine-avid lesions following 131I therapy
ConclusionIt was inferred that dose estimation after RIT with SPECT/CT is feasible to apply, together with good agreement with published124I PET/CT dose estimates. A broad and sub-effective dose range was estimated for thyroid residues and distal lesions. Moreover, the current methodology might be useful for establishing a dose –effect relationship and radiation-induced salivary glands damage after RIT.
Source: Health and Technology - Category: Information Technology Source Type: research
More News: Cancer | Cancer & Oncology | Information Technology | Iodine | PET Scan | Radioiodine Therapy | SPECT | Study | Thyroid | Thyroid Cancer